◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › TTRX

Turn Therapeutics Inc. (TTRX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-10

Turn Therapeutics Inc. (TTRX) operates in the Biotechnology industry and is headquartered in Westlake Village, United States with about 2 employees. Its market capitalization is roughly $262 million.

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.

Interactive charts & full statements →

TTRX Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-31
Total Revenue$0M$0M
Operating Income (EBIT)($2M)($2M)
Net Income($2M)($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TTRX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-09-302025-06-302025-03-31
Total Revenue$0M
Operating Income (EBIT)($1M)
Net Income($1M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TTRX Free Cash Flow History

TTRX Balance Sheet History

Balance sheet2024-12-312023-12-31
Total Assets$2M$2M
Total Liabilities$2M$2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TTRX viewer.

Other Companies in Biotechnology

← TTMIAll stocksTTWO →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.